ET Startup Awards 2026 | Top Innovator: Deeptech startup Theranautilus’ micro robots score big win
Deeptech startup Theranautilus has won the Top Innovator award at the ET Startup Awards 2026 for its work on microscopic robots that can navigate the human body for targeted treatments. Founded in 2020, the Bengaluru-based startup is developing th...

The jury said the nominees this year reflected a broader shift in Indian entrepreneurship towards solving complex scientific and technological problems.

“What really stood out to me is their patience. True innovation takes time. Many of the companies we evaluated today have spent years quietly building, refining their technology and staying the course, patiently waiting for monetisation and scale,” said Mukesh Bansal, jury member and cofounder of Myntra, Curefit and Nurix.
Also Read: ET Startup Awards 2026: Groww adjudged No. 1; Sauce VC’s Manu Chandra named Midas Touch winner
For Abhiraj Singh Bhal, another jury member and the cofounder and CEO of Urban Company, what set Theranautilus apart was that it was a globally unique innovation rooted in fundamental research. “It has reached a point where commercialisation is becoming a reality, and there is a lot of peer-reviewed research around it. That played significantly in its favour,” he said.
Founded in Bengaluru in 2020 by Ambarish Ghosh, Peddi Shanmukh Srinivas and Debayan Dasgupta, Theranautilus traces its roots to research started by Ghosh at the Indian Institute of Science in 2007.
The company is developing magnetically controlled nanorobots that can navigate narrow pathways inside the body, carry therapeutic payloads and perform targeted interventions.
Its first focus is oral healthcare, where the technology is being developed to treat dental sensitivity and access hard-to-reach areas such as root canals. The company has completed preclinical studies in mice and is moving towards human trials by September 2026.
Theranautilus plans to eventually apply the platform to oncology, drug delivery, ophthalmology and neuromodulation. For oncology, trials of nanorobots are targeted for 2028.
“We at Theranautilus are deeply honoured and humbled to receive the prestigious Economic Times Top Innovator Award. This platform validates our relentless pursuit of pioneering nanobots in healthcare and inspires us to push boundaries further and accelerate our mission of transforming patient care through innovation,” said Peddi Shanmukh Srinivas, cofounder and chief executive of Theranautilus.
The company's ambition goes beyond its first dental application. Srinivas said Theranautilus is working to bring physicist Richard Feynman's 1959 vision of a “swallowed surgeon” closer to reality. “By deploying nanorobots capable of precise, cellular-scale interventions we are turning theory into life-saving treatments, paving the way for non-invasive healthcare that operates at nanoscale,” he added.
Theranautilus plans to commercialise the technology through licensing partnerships with pharmaceutical, healthcare and medical-device companies, rather than manufacturing individual products for every application. It has raised Rs 65 crore, including equity-free grants, and is backed by pi Ventures, Pravega Ventures, Golden Sparrow and Angel investor Abhishek Goyal.
Other contenders
Ethereal Exploration Guild (EtherealX)

4baseCare

QNu Labs

Agrani Labs

The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.